VYVGART Hytrulo 180 mg/mL
efgartigimod alfa and hyaluronidase (human recombinant) · INJECTION, SOLUTION · argenx US
Vyvgart Hytrulo is a prescription injection used to treat myasthenia gravis, a condition where the immune system attacks muscles and causes weakness. It works by reducing antibodies that interfere with muscle function.
Key Facts
- Brand Name
- VYVGART Hytrulo
- Generic Name
- efgartigimod alfa and hyaluronidase (human recombinant)
- NDC Code (Product)
73475-3102- Manufacturer
- argenx US
- Strength
- 180 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761304
- Drug Class
- Endoglycosidase [EPC]; Neonatal Fc Receptor Blocker [EPC]
- Marketing Start
- 06/20/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is VYVGART Hytrulo used for?
Vyvgart Hytrulo is a prescription injection used to treat myasthenia gravis, a condition where the immune system attacks muscles and causes weakness. It works by reducing antibodies that interfere with muscle function.
Is VYVGART Hytrulo a controlled substance?
VYVGART Hytrulo is not classified as a controlled substance by the DEA.
What is the generic name for VYVGART Hytrulo?
The generic name for VYVGART Hytrulo is efgartigimod alfa and hyaluronidase (human recombinant). There are no other listed brand versions of efgartigimod alfa and hyaluronidase (human recombinant).
What is the NDC code for VYVGART Hytrulo 180 mg/mL?
The NDC (National Drug Code) for VYVGART Hytrulo 180 mg/mL is 73475-3102, listed by argenx US.
Other VYVGART Hytrulo Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)